ERBB4

protein-coding

erb-b2 receptor tyrosine kinase 4, the group of Erb-b2 receptor tyrosine kinases|MicroRNA protein coding host genes

Gene summary

This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]

MANE transcript

NM_005235.3

Inheritance

AD

ClinVar variants

P:12U:342B:170

Top phenotype

Amyotrophic lateral sclerosis 19

gnomAD constraint

pLI —, LoF o/e 0.16

Max pathogenic AF

—

Genomic locus

chr2:211,375,717-212,538,841

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~1,163.1 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

intellectual disabilitySTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0001071

Submitter: PanelApp Australia

amyotrophic lateral sclerosis type 19MODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0014223

Submitter: Genomics England PanelApp

amyotrophic lateral sclerosisSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0004976

Submitter: Orphanet

amyotrophic lateral sclerosis type 19LIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0014223

Submitter: ClinGen

ERBB4 was first reported in relation to autosomal dominant amyotrophic lateral sclerosis 19 (meaning amyotrophic lateral sclerosis caused by variants in the ERBB4 gene rather than a distinct ALS phenotype) in 2013 (Takahashi et al., PMID:24119685). Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative disease involving death or loss of function of upper and lower motor neurons. ERBB4 is a membrane-bound receptor tyrosine kinase which binds ligands such as neuregulin, dimerises, usually with ErbB2 or ErbB3, and auto-phosphorylates on activation. At least 19 unique ERBB4 variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level and experimental data. 2.9 points have been given for variants in this gene which have been reported in at least 7 publications (PMIDs: 24119685; 32065797; 32166880; 33414559; 31788332; 31432357; 28889094). The seminal paper (Takahashi et al., 2013 PMID:24119685) identified ERBB4 as a candidate gene in a family of 3 affected siblings, based on an assumption of reduced penetrance. A de novo variant in ERBB4 in a person with sporadic ALS was identified as part of this study. Other publications consist of a case study of an individual with ALS-FTD, and genetic epidemiology studies involving genotyping people enrolled in specialist ALS clinics and screening for variants in known or implicated ALS genes. The mechanism for disease is unknown. This gene-disease association is supported by an immunohistochemistry study (PMID: 31124187) investigating ErbB4 expression in the central nervous system of people with sporadic ALS compared to non-neuro disease controls and neuro disease controls. The study showed there was reduced ErbB4 in motor neurons correlating with severity of motor neuron loss, that the subcellular localization of ErbB4 was altered in people with sporadic ALS – ErbB4 was found in the nucleolus, in spheroids (previously associated with ALS pathogenicity) and in glial cells. There was a negative correlation between pathogenic subcellular localization of TDP-43 and presence of ErbB4 in motor neurons. ERBB4 mouse knock-out models produce an altered neuronal phenotype, but not an ALS phenotype (PMIDs: 14555954; 12824469; 15543145; 15976301).

amyotrophic lateral sclerosis type 19STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014223

Submitter: Labcorp Genetics (formerly Invitae)

amyotrophic lateral sclerosis type 19LIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0014223

Submitter: Ambry Genetics

Clinical Genomic Database (CGD)

Amyotrophic lateral sclerosis 19AD

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 24119685Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ERBB4 variants in ClinVar

14 Conditions Cataloged
not providedTotal: 509
Inborn genetic diseasesTotal: 93
ERBB4-related disorderTotal: 87
not specifiedTotal: 38
Amyotrophic lateral sclerosis type 19Total: 28
Amyotrophic lateral sclerosisTotal: 9
SchizophreniaTotal: 2
Amyotrophic lateral sclerosis type 10Total: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005235.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
139
clinvar
10
clinvar
155
missense
1
clinvar
4
clinvar
315
clinvar
21
clinvar
341
nonsense
1
clinvar
4
clinvar
5
start loss
0
frameshift
2
clinvar
1
clinvar
6
clinvar
9
splice donor/acceptor (+/-2bp)
3
clinvar
11
clinvar
14
Total3934216010524

Highest pathogenic variant AF is 0.00003469873

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 17 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005235.3RefSeqNP_005226.128MANE Select
ENST00000342788.9EnsemblENSP00000342235.428MANE Select
NM_001042599.2RefSeqNP_001036064.127Standard
NM_001439005.1RefSeqNP_001425934.128Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
erbb4aDanio rerio

Structure: optic tectum

Quality: decreased process quality

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • PI3K-Akt signaling pathway - Homo sapiens (human)
  • ErbB signaling pathway - Homo sapiens (human)
  • Calcium signaling pathway - Homo sapiens (human)
  • MAPK signaling pathway - Homo sapiens (human)
  • Proteoglycans in cancer - Homo sapiens (human)

Biological Process

  • MAPK cascade
  • neural crest cell migration
  • positive regulation of protein phosphorylation
  • signal transduction
  • transmembrane receptor protein tyrosine kinase signaling pathway

Molecular Function

  • protein tyrosine kinase activity
  • transmembrane receptor protein tyrosine kinase activity
  • Ras guanyl-nucleotide exchange factor activity
  • epidermal growth factor receptor binding
  • protein binding

Cellular Component

  • extracellular region
  • nucleus
  • nucleoplasm
  • mitochondrion
  • mitochondrial matrix

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000342788
Coding exons
28
Length
1163120
Individuals with no LoFs
125729
Homozygous LoFs
0
Heterozygous LoFs
19
Defined
125748
p
0.0000756
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.015767290.7900.00003948616
Missense (PolyPhen)119218.550.544512633
Synonymous-2.233002551.180.00001342472
Loss of Function6.631273.30.1640.00000404850

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000180.00018rare
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish0.0000990.000099rare
East Asian0.000220.00022rare
Finnish0.0000920.000092rare
European (Non-Finnish)0.0000440.000044rare
South Asian0.0000980.000098rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis. Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially for normal neural crest cell migration and normal axon guidance. Required for mammary gland differentiation, induction of milk proteins and lactation. Acts as cell-surface receptor for the neuregulins NRG1, NRG2, NRG3 and NRG4 and the EGF family members BTC, EREG and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Ligand specificity and signaling is modulated by alternative splicing, proteolytic processing, and by the formation of heterodimers with other ERBB family members, thereby creating multiple combinations of intracellular phosphotyrosines that trigger ligand- and context-specific cellular responses. Mediates phosphorylation of SHC1 and activation of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Isoform JM-A CYT-1 and isoform JM-B CYT-1 phosphorylate PIK3R1, leading to the activation of phosphatidylinositol 3-kinase and AKT1 and protect cells against apoptosis. Isoform JM-A CYT-1 and isoform JM-B CYT-1 mediate reorganization of the actin cytoskeleton and promote cell migration in response to NRG1. Isoform JM-A CYT-2 and isoform JM-B CYT-2 lack the phosphotyrosine that mediates interaction with PIK3R1, and hence do not phosphorylate PIK3R1, do not protect cells against apoptosis, and do not promote reorganization of the actin cytoskeleton and cell migration. Proteolytic processing of isoform JM-A CYT-1 and isoform JM-A CYT-2 gives rise to the corresponding soluble intracellular domains (4ICD) that translocate to the nucleus, promote nuclear import of STAT5A, activation of STAT5A, mammary epithelium differentiation, cell proliferation and activation of gene expression. The ERBB4 soluble intracellular domains (4ICD) colocalize with STAT5A at the CSN2 promoter to regulate transcription of milk proteins during lactation. The ERBB4 soluble intracellular domains can also translocate to mitochondria and promote apoptosis. {ECO:0000269|PubMed:10348342, ECO:0000269|PubMed:10353604, ECO:0000269|PubMed:10358079, ECO:0000269|PubMed:10722704, ECO:0000269|PubMed:10867024, ECO:0000269|PubMed:11178955, ECO:0000269|PubMed:11390655, ECO:0000269|PubMed:12807903, ECO:0000269|PubMed:15534001, ECO:0000269|PubMed:15746097, ECO:0000269|PubMed:16251361, ECO:0000269|PubMed:16778220, ECO:0000269|PubMed:16837552, ECO:0000269|PubMed:17486069, ECO:0000269|PubMed:17638867, ECO:0000269|PubMed:19098003, ECO:0000269|PubMed:20858735, ECO:0000269|PubMed:8383326, ECO:0000269|PubMed:8617750, ECO:0000269|PubMed:9135143, ECO:0000269|PubMed:9168115, ECO:0000269|PubMed:9334263}.;
Disease
DISEASE: Amyotrophic lateral sclerosis 19 (ALS19) [MIM:615515]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5- 10% of the cases. {ECO:0000269|PubMed:24119685}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.402

Intolerance Scores

LoFtool
0.147
RVIS EVS
-1.97
RVIS percentile EVS
1.79

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.975

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.